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        Introduction 
  Elevated levels of eukaryotic initiation factor 4E (eIF4E) are as-
sociated with oncogenic transformation in cell culture, tumori-
genesis in mouse models, and poor prognosis in a signifi  cant 
subset of human cancers (  Graff and Zimmer, 2003  ). eIF4E pro-
motes proliferation and rescues cells from a variety of apoptotic 
stimuli, including serum deprivation (  Polunovsky et al., 1996  ; 
  Sonenberg and Gingras, 1998  ;   Tan et al., 2000; Graff and 
  Zimmer, 2003  ). At the molecular level, eIF4E modulates gene 
expression at two distinct levels: mRNA translation and mRNA 
nuclear export (for review see   Culjkovic et al., 2007  ). To act in 
either of these processes, eIF4E must bind the 7-methyl guano-
sine (m 
7  G) cap moiety found on the 5     end of mRNAs (for re-
view see  Culjkovic et al., 2007 ). In the cytoplasm, eIF4E recruits 
mRNA to the ribosome as a critical step in translation initiation 
(  Sonenberg and Gingras, 1998  ). Not all transcripts are affected 
equally by eIF4E (  Rousseau et al., 1996  ;   Sonenberg and Gingras, 
1998; Clemens and Bommer, 1999  ;   Mamane et al., 2007;   for 
review see   Culjkovic et al., 2007  ). For instance, the translation 
of a subset of genes with complex 5     untranslated regions 
(UTRs) is more sensitive to eIF4E levels (and are deemed eIF4E 
sensitive) than transcripts with short, unstructured UTRs. In this 
case, translation enhancement is defi  ned as the association of 
these transcripts with heavier polysomes. In the nucleus, eIF4E 
up-regulates the mRNA export of a substantial subset of growth-
promoting mRNAs that contain a 50-nucleotide element known 
as the 4E sensitivity element (4E-SE) in their 3     UTR (for re-
view see   Culjkovic et al., 2007  ). Therefore, increased protein 
production of the corresponding export-sensitive mRNAs arises 
through two mechanisms: fi  rst, a concentration effect whereby 
the increased levels of cytoplasmic transcripts means that more 
protein is made; and second, a subset of these transcripts are 
subsequently loaded more effi  ciently onto the heavier poly-
somes because they are translationally sensitive to eIF4E. Thus, 
eIF4E affects gene expression at multiple levels. 
  Recent studies indicate that there is a poor correlation be-
tween the proteomes and transcriptomes of cells ( Lu et al., 2006 ). 
This implies that posttranscriptional regulation plays a critical role 
in gene expression and thereby impacts the resulting physiology 
  E
ukaryotic initiation factor 4E (eIF4E) promotes cellu-
lar proliferation and can rescue cells from apoptotic 
stimuli such as serum starvation. However, the mecha-
nisms underlying apoptotic rescue are not well understood. 
In this study, we demonstrate that eIF4E overexpression 
leads to enhanced survival signaling through Akt and that 
eIF4E requires Akt1 to rescue serum-deprived ﬁ  broblasts. 
Furthermore, a mutant form of eIF4E (W73A), which is 
messenger RNA (mRNA) export competent but does not 
promote translation, rescues cells as readily as wild-type 
eIF4E. We show that eIF4E mediates Akt activation via up-
regulation of Nijmegen breakage syndrome 1 (NBS1), a 
phosphoinositide-3 kinase  –  Akt pathway upstream activator. 
Additionally, eIF4E coordinately up-regulates the expression 
of downstream effectors of the Akt pathway, thereby am-
plifying Akt signaling effects. A negative regulator of eIF4E, 
the promyelocytic leukemia protein (PML), suppresses Akt 
activation and apoptotic rescue. These PML activities likely 
arise, at least in part, through its inhibition of eIF4E-mediated 
NBS1 mRNA export. In summary, eIF4E coordinately regu-
lates gene expression to potentiate Akt activation, an activ-
ity required for apoptotic rescue.
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  In this study, we examine the possibility that eIF4E res-
cues cells from apoptotic cell death by coordinately regulating 
the expression of factors in such networks to achieve cell sur-
vival. We demonstrate that eIF4E potentiates Akt activation and 
that this activity is required for its ability to rescue cells from 
serum  deprivation – induced  apoptosis.  The  RNA  regulon  model 
serves as a theoretical context to understand how eIF4E coordi-
nately and potently activates the Akt signaling pathway. First, 
eIF4E overexpression leads to the up-regulation of Nijmegen 
breakage syndrome 1 (NBS1) expression, a factor that potenti-
ates the phosphorylation of Akt (  Chen et al., 2005, 2008  ;   Sagan 
et al., 2007  ). Second, eIF4E overexpression leads to the coordi-
nated mRNA export and thereby up-regulation of several down-
stream effectors of Akt. Reciprocally, a cellular inhibitor of 
eIF4E, the promyelocytic leukemia protein (PML), inhibits 
eIF4E-dependent Akt activation and also reduces the expression 
of a subset of downstream effectors of Akt. In this way, eIF4E 
and PML coordinately modulate an RNA regulon, which con-
trols the Akt pathway and thus impacts cell survival. 
  Results 
  eIF4E overexpression promotes 
Akt activation 
  We examined the possibility that eIF4E overexpression leads 
to the activation of Akt. Akt activation was assessed by moni-
toring its phosphorylation at T308 and S473 using phospho-
specifi  c antibodies in immortalized mouse embryonic fi  broblasts 
(MEFs). Phosphorylation of these two regulatory sites is a 
well-characterized indicator of Akt activation (  Alessi et al., 
1996  ;   Stokoe et al., 1997  ;   Nicholson and Anderson, 2002  ; 
of the cell. Keene and colleagues proposed the RNA regulon 
model to describe a means by which posttranscriptional gene 
regulation can be coordinated (  Keene and Tenenbaum, 2002; 
Keene and Lager, 2005  ;   Keene, 2007  ). In this model, the ex-
pression of transcripts that act in the same biological pathway, 
such as cell cycle progression, is coordinately controlled by the 
presence of elements in the 3     and/or 5     UTR of these mRNAs. 
These RNA elements are referred to as untranslated sequence 
elements for regulation (USER) codes. For example, a set of 
mRNAs, which encode proteins involved in the same biochemi-
cal pathway, would have their mRNA export coordinated by 
having a common USER code in their 3     UTR, such as the 
4E-SE. The USER codes work by recruiting proteins involved in 
a given process to the RNAs in question to facilitate said process. 
Thus, mRNAs containing the 4E-SE USER code would recruit 
the appropriate export factors to the RNAs, facilitating the ex-
port process. Any level of RNA metabolism could be modulated 
this way as long as the appropriate USER codes were present. 
  Our studies strongly suggest that eIF4E is a node in an 
RNA regulon governing cell cycle progression by (at least in 
part) the combinatorial modulation of the export of a wide vari-
ety of transcripts involved in nearly every step of the cell cycle. 
Similarly, translationally sensitive mRNAs likely contain USER 
codes in their 5     UTR (  Mamane et al., 2007  ). In this way, con-
trol at the mRNA export and translation levels can be decoupled 
(i.e., mRNAs would require both the 3     4E-SE and the 5     USER 
code to be modulated by eIF4E at both levels). This model of 
gene expression provides network level control of the fate of 
mRNAs that encode proteins involved in the same biochemical 
and thus biological processes. Control of nodes (such as eIF4E) 
in these regulons is critical for determining the fate of the cell. 
  Figure 1.       The elevated expression of eIF4E alters the activity of Akt1 and downstream effectors.   (A) Western blot analysis of whole cell extracts from cells 
overexpressing eIF4E wild type or mutants in Akt wild-type and Akt1 
    /      cells. (B) Western blot analysis of whole cell extracts from Akt wild-type cells treated 
with the PI3K inhibitor LY294002 (LY; 50   μ  M for 1 h). (C) Western blot analysis of whole cell extracts from NIH3T3 cells transfected with two different 
siRNAs for eIF4E (si eIF4E) or scrambled controls (scram). The detected proteins are as indicated.     -Actin or GAPDH is shown as a loading control.     53   EI  F4E RNA REGULON PROMOTES A  KT   SIGNALING   •   CULJKOVIC ET AL.
eIF4E modulates some other signaling pathways that regulate 
mTOR (  Dennis et al., 2001  ;   Chen and Fang, 2002  ;   Arsham and 
Simon, 2003  ;   Wang et al., 2003; Brugarolas et al., 2004  ;   Roux 
et al., 2004  ;   Shaw et al., 2004  ). 
  We next tested whether eIF4E-mediated Akt activation 
occurred in a phosphoinositide-3 kinase (PI3K)  –  dependent 
manner. In cells overexpressing eIF4E, there is clearly more 
phosphorylation of Akt at both T308 and S473 relative to vector 
controls. Thus, we monitored the effects of inhibiting PI3K with 
LY294002 (  Yao and Cooper, 1995  ) in eIF4E-overexpressing 
cells. This led to a drastic reduction in the activating phosphory-
lation of Akt, whereas Akt levels were not altered (  Fig. 1 B  ). 
However, LY294002 treatment did not impede the eIF4E-
dependent increases in NBS1, an eIF4E-dependent mRNA export 
target (  Fig. 1 B  ;   Culjkovic et al., 2006  ). Thus, PI3K signaling 
does not alter eIF4E  ’  s mRNA export activity for the transcripts 
examined. As expected, LY294002 inhibited the phosphory-
lation of S6 and 4E-BP1 (  Fig. 1 B  ;   Sanchez-Margalet et al., 1994; 
Gingras et al., 1998  ). 
  eIF4E requires Akt1 for its 
survival functions 
  We examined the relevance of Akt activation to eIF4E  ’  s estab-
lished physiological effects in cell survival. The ability of eIF4E 
to rescue wild-type or Akt1 
   /     cells from serum deprivation  –
    induced apoptosis was monitored by fl  ow cytometry using 
  annexin V/propidium iodide (PI) staining and by TUNEL analy-
sis (  Fig. 2 A   and Table S1, available at http://www.jcb.org/cgi/ 
content/full/jcb.200707108/DC1). Cells cultured in serum are 
shown as a control. eIF4E overexpression rescued wild-type cells 
(    80% viable cells) as compared with vector controls (   40% 
viable cells). The extent of rescue is similar to that shown in 
the original study describing the survival function of eIF4E 
(  Polunovsky et al., 1996  ). Interestingly, the mRNA export-com-
petent mutant (W73A) rescued cells to a similar extent (   80%) 
as cells overexpressing wild-type eIF4E. This suggests that eIF4E ’ s 
rescue function is mediated, at least in part, via its mRNA ex-
port function. In contrast, the inactive W56A eIF4E mutant 
did not rescue cells, with a similar number of viable cells as the 
vector controls. 
 A  comparison  of  Akt1 
   /     cells versus wild-type cells 
showed that Akt1 
   /     cells had slightly reduced viability upon 
serum deprivation (    20 vs.     40%). This reduction in viabil-
ity was observed in another study involving serum deprivation 
of these cells (  Chen et al., 2001  ). Strikingly, neither wild-type 
eIF4E nor the W73A mutant rescued Akt1 
   /     cells from apop-
tosis. In both cases, the number of viable cells was around 20%, 
the same as seen in the vector controls. As a control, we ex-
amined whether the antiapoptotic factor Bcl2 rescued Akt1 
   /    
cells. Substantially more viable Akt1 
   /     cells (    85%) were pre-
sent upon the overexpression of Bcl2, indicating that these cells 
can be rescued from apoptosis (  Fig. 2 A   and Fig. S1 B, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200707108/DC1), 
which is consistent with another study showing that Bcl2 res-
cued these cells (  Skeen et al., 2006  ). Thus, eIF4E  ’  s survival 
function in the context of serum deprivation requires the pres-
ence of Akt1. 
  Vivanco and   Sawyers, 2002; Song et al., 2005  ). eIF4E over-
expression signifi  cantly increased the phosphorylation of Akt at 
both sites (  Fig. 1 A  ). Importantly, the m 
7 G  cap – binding  mutant 
of eIF4E (W56A), which is unable to act in translation or mRNA 
export (  Cohen et al., 2001  ;   Culjkovic et al., 2006  ), does not have 
this effect. In contrast, an eIF4E mutant (W73A) that acts in mRNA 
export but does not promote translation of sensitive mRNAs 
(  Culjkovic et al., 2005, 2006  ) because of its reduced affi  nity for 
eIF4G also activates Akt. Consistent with Akt activation, eIF4E 
and W73A mutant overexpression leads to enhanced phosphory-
lation of ribosomal protein S6 and eIF4E-binding protein 1 
(4E-BP1), whereas the W56A mutant is inactive (  Fig. 1 A  ). Similar 
experiments in other cell types (NIH3T3, U2Os, and U937) pro-
duced the same pattern of results, showing that these effects are 
not cell line restricted. Overexpression of wild-type or mutant 
forms of eIF4E did not affect total Akt levels. 
  There has been a recent study suggesting that it is not pos-
sible to overexpress the W73A mutant to levels comparable with 
wild-type eIF4E (  Wendel et al., 2007  ). We note that both our 
group and   Dostie et al. (2000  ;   Cohen et al., 2001  ;   Topisirovic 
et al., 2003b; Culjkovic et al., 2006  ) have had no diffi  culty in over-
expressing this mutant. We have noted that when using the 2Flag 
system, W73A levels are reduced (unpublished data); thus, we 
avoid these systems, opting for other tags (or no tags) such as 
myc or HA that do not have this issue. 
  Experiments were extended to determine the effects of 
knocking down eIF4E expression using two different siRNAs 
and comparing these results with cells treated with scrambled 
controls (  Fig. 1 C  ). Both siRNAs reduced eIF4E protein levels 
as expected. Consistent with these results, reduction of eIF4E 
levels by either siRNA in NIH3T3 cells led to decreased levels 
of cyclin D1 and NBS1 proteins relative to scrambled controls 
( Fig. 1 C ). Furthermore, eIF4E knockdown led to decreased lev-
els of Akt phosphorylation and decreased phosphorylation of 
  ribosomal protein S6 and 4E-BP1 (  Fig. 1 C  ). 
  To determine the importance of Akt1 to the apoptotic res-
cue activity of eIF4E, we examined Akt1 
   /     MEFs (  Cho et al., 
2001  ) overexpressing eIF4E. Akt1 is the prevalent Akt isoform 
in embryonic fi  broblasts. The aforementioned wild-type fi  bro-
blasts are from the littermate controls for these Akt1 
   /     cells. 
The Akt antibody used recognizes all three isoforms of Akt and, 
thus, explains the immunoreactivity of Akt1 
   /     cell lysates (  Fig. 
1 A  ). Because of the very low levels of these proteins in fi  bro-
blasts (  Cho et al., 2001  ), we were not able to detect phosphory-
lated Akt2 and 3. As expected, eIF4E does not induce the 
phosphorylation of Akt1 as a result of its absence. There is more 
phospho  –  4E-BP1 and phospho-S6 in general in Akt wild-type 
versus Akt1 
   /     cells, with no alteration in the total levels of 
4E-BP1 or S6. Interestingly, eIF4E still elevates 4E-BP1 and S6 
phosphorylation in Akt1 
   /     cells (without changing the total 
levels of either protein), suggesting that Akt2, Akt3, or some 
other kinase activates the mammalian target of rapamycin 
(mTOR) and, thereby, leads to phosphorylation of these pro-
teins in the absence of Akt1. This is consistent with previous 
observations that Akt2 and Akt3 activate mTOR (  Peng et al., 
2003  ;   Easton et al., 2005  ;   Skeen et al., 2006; Brognard et al., 
2007  ;   Shiratsuchi and Basson, 2007  ). It is also possible that JCB • VOLUME 181 • NUMBER 1 • 2008  54 
  Figure 2.       Akt1 is required for eIF4E-mediated apoptotic rescue of serum-starved cells.   (A) The panels shown are representative ﬁ  elds from TUNEL experiments 
(blue, DAPI [viable]; red, apoptotic) of eIF4E-overexpressing cells derived from Akt wild-type and Akt1 
    /      cells. Graphs represent quantitative measurements 
by ﬂ  ow cytometry of apoptosis using annexin V and PI staining of the indicated cells. Bar color is as follows: annexin V 
     /PI 
     , blue; annexin V 
+  /PI 
     , yellow; 
annexin V 
+  /PI 
+  , red; annexin V 
     /PI 
+  , black. (B) Western blot analysis of whole cell extracts from Akt1 
    /      cells overexpressing eIF4E and/or Akt1 as indicated 
(Akt wild-type cells [second lane] are shown for comparison).     -Actin is shown as a loading control. (C) Quantiﬁ  cation of viability (blue bars) from apoptosis 
assays of Akt1 add back into Akt1 
    /      cells. Viability was assessed by ﬂ  ow cytometry using annexin V and PI. All errors from apoptosis assays were within 
10% (Table S1, available at http://www.jcb.org/cgi/content/full/jcb.200707018/DC1). NC, normal condition; SS, serum starvation. Bars, 50   μ  m.     
  To further establish the dependence of eIF4E on Akt1, we 
reintroduced Akt1 into Akt1 
   /     cells and monitored the ability of 
eIF4E to rescue cells from serum deprivation  –  induced apoptosis 
(  Fig. 2, B and C  ). Reintroduction of Akt1 into Akt1 
   /     cells  re-
stored the ability of eIF4E to rescue cells from serum depriva-
tion, indicating that Akt1 is required for the apoptotic rescue 
function of eIF4E under these conditions and is not a con-
sequence of some other/additional issue with the Akt1 
   /     cells. 55   EI  F4E RNA REGULON PROMOTES A  KT   SIGNALING   •   CULJKOVIC ET AL.
(  Rousseau et al., 1996; Culjkovic et al., 2005, 2006  ). Our results 
show that overexpression of eIF4E or the W73A export-competent 
mutant promoted cyclin D1 mRNA export in either wild-type or 
Akt1 
   /     cells as compared with vector controls. Another eIF4E-
dependent mRNA export target, NBS1 (  Culjkovic et al., 2005, 
2006  ), gave similar results. We confi  rmed that eIF4E-dependent 
mRNA export was associated with increased protein production 
of cyclin D1 and NBS1 (  Fig. 3 B  , bottom). Furthermore, over-
expression of the W73A mutant (which is competent in export 
but does not enhance translation) leads to increased cyclin D1 
and NBS1 protein levels, which is consistent with their en-
hanced nuclear mRNA export. Export of negative control 
mRNAs (glyceraldehyde-3-phosphate dehydrogenase [GAPDH], 
actin, and VEGF) is unchanged (  Fig. 3 B   and not depicted). 
Thus, eIF4E export is intact in the Akt1 
   /     cells. 
  In addition, we examined the possibility that the loss of 
Akt1 impaired eIF4E-sensitive translation. We examined the 
  Loss of Akt1 does not impair eIF4E  ’  s 
mRNA export or translation functions 
  The results in Akt1 
   /     cells suggest that one or more biochemi-
cal activities of eIF4E could be impaired by the loss of Akt1 
and/or that eIF4E modulates the expression of target genes 
involved in activation of the Akt pathway. First, we examined 
whether eIF4E-dependent mRNA export was impaired in Akt1 
   /    
cells compared with wild-type controls (  Fig. 3 A ).  We  examined 
the nuclear export of cyclin D1 mRNA by monitoring the mRNA 
content in cytoplasmic versus nuclear fractions using real-time 
quantitative PCR (qPCR) as we described previously (  Culjkovic 
et al., 2005, 2006  ). tRNA  lys   and U6 small nuclear RNA are frac-
tionation controls for monitoring the quality of cytoplasmic and 
nuclear fractions, respectively (  Culjkovic et al., 2005, 2006  ). 
Graphs represent the ratio of cytoplasmic to nuclear levels of the 
indicated mRNAs (  Fig. 3 A  , top). Cyclin D1 mRNA was chosen, 
as it is the best-described eIF4E-dependent mRNA export target 
  Figure 3.       The absence of Akt1 does not impede eIF4E-dependent nuclear export of examined sensitive RNA targets.   (A) RNA quantiﬁ  cation from qPCR ex-
periments from Akt1 wild-type and Akt1 
    /      cells show the relative fold increase of the cytoplasmic/nuclear (C/N) ratio of NBS1, cyclin D1 (positive control 
for eIF4E-dependent mRNA export), and VEGF (negative control) mRNAs. Cytoplasmic/nuclear ratios represent relative fold   ±   SD (error bars) normalized 
to vector control, which was set to 1. Averaged values were normalized to GAPDH. The bottom panels are controls for sample fractionation (U6 small 
nuclear RNA, nuclear; tRNA  lys  , cytoplasmic). (B) Control experiment showing total levels of NBS1, cyclin D1, or VEGF RNA, with Western analysis below 
indicating changes at the protein expression level.     JCB • VOLUME 181 • NUMBER 1 • 2008  56 
Two recent studies also showed that NBS1 is involved in the 
suppression of apoptosis after      irradiation (  Ohnishi et al., 2006  ; 
  Sagan et al., 2007  ) and that this relied on its effects on the Akt 
pathway (  Sagan et al., 2007  ). Thus, we examined the possibility 
that the ability of eIF4E to activate Akt relied, at least in part, 
on its ability to modulate the expression of NBS1. As shown in 
  Fig. 1  , eIF4E overexpression led to the up-regulation of NBS1 
mRNA export, similar to that observed for cyclin D1 mRNA 
(  Fig. 3 B  , top;   Rousseau et al., 1996  ). This was correlated with 
increased levels of NBS1 protein and was independent of the 
presence or absence of Akt1 (  Fig. 3 B  , bottom). 
  These observations led us to hypothesize that NBS1 is a 
key effector of eIF4E-dependent activation of Akt under these 
conditions. To determine whether eIF4E required NBS1 for Akt 
activation, the expression of NBS1 was silenced using RNA inter-
ference in NIH3T3 and Akt wild-type MEFs. Western blot 
analysis confi  rmed the effi  ciency of NBS1 siRNA (  Fig. 4 A   
and Fig. S3 A, available at http://www.jcb.org/cgi/content/full/
jcb.200707018/DC1). As shown previously, knockdown of 
NBS1 led to reduced activation of Akt and its downstream 
  effectors, which is consistent with a role for endogenous NBS1 
in Akt activation (  Chen et al., 2005, 2008  ). Importantly, siRNA 
treatment for NBS1 did not alter the expression of eIF4E or Akt 
(  Figs. 4 A   and S3 A) nor the export or RNA levels of eIF4E 
mRNA targets cyclin D1 or VEGF (Figs. S2 [A and B] and S3 
[C and D]). We observed that if NBS1 expression is reduced by 
siRNA treatment, eIF4E overexpression no longer increases the 
phosphorylation of Akt at either T308 or S473 compared with 
scrambled siRNA controls in both NIH3T3 and Akt wild-type 
MEFs (  Fig. 4 A   and Fig. S3 A, respectively). 
 To  confi  rm that NBS1 did not affect the ability of eIF4E 
to modulate mRNA export, we examined mRNA export in 
levels of VEGF protein, a well-established translational target 
of eIF4E (  Clemens and Bommer, 1999  ). Clearly, the loss of 
Akt1 did not impair the ability of eIF4E to promote VEGF trans-
lation relative to vector controls ( Fig. 3 B , bottom). Consistently, 
VEGF protein levels were not changed by the W73A export-
competent/translationally impaired eIF4E mutant. Note that 
there was no change in the total mRNA levels of cyclin D1, 
NBS1, or VEGF as monitored by qPCR as a function of eIF4E 
or mutant overexpression (  Fig. 3 B  , top). In summary, the loss 
of Akt1 does not impair eIF4E-dependent mRNA export or 
translation of the eIF4E-sensitive transcripts examined. This led 
us to hypothesize that one (or more) of the mRNA targets of 
eIF4E potentiates Akt activation. 
  The eIF4E-dependent mRNA export target 
NBS1 is important for eIF4E-dependent 
Akt activation 
  We previously demonstrated that the ability of eIF4E to coordi-
nately modulate mRNA export of a wide variety of transcripts 
contributes to its proliferative potential (  Culjkovic et al., 2005, 
2006  ). Inspection of these mRNA targets revealed a potential 
mechanism for eIF4E-mediated activation of Akt. eIF4E over-
expression led to enhanced mRNA export of NBS1 (  Culjkovic 
et al., 2006  ). Traditionally, NBS1 has been associated with DNA 
double-strand break repair (  Costanzo et al., 2001  ). However, re-
cent experiments revealed that elevation of NBS1 results in the 
activation of PI3K and subsequent activation of Akt and its 
downstream effectors (  Chen et al., 2005  ). In fact, endogenous 
NBS1 impacts Akt signaling (  Chen et al., 2005, 2008  ;   Sagan et al., 
2007  ). NBS1 overexpression is associated with proliferation and 
oncogenic transformation in cell culture and tumorigenesis in xe-
nograft mouse models ( Chen et al., 2005 ;  Yang et al., 2006, 2007 ). 
  Figure 4.       NBS1 expression is necessary for up-regulation of the Akt1 pathway by eIF4E.   (A) Western blot analysis of whole cell extracts from siRNA-
treated NIH3T3 ﬁ  broblasts overexpressing eIF4E. Scram, scrambled control; siNBS1, extracts from cells treated with siRNA for NBS1. The proteins detected 
are as indicated.     -Actin is shown as a loading control. (B) Quantiﬁ  cation of viable cells from apoptosis assays (annexin V 
     /PI 
     ) of siNBS1-treated NIH3T3 
ﬁ  broblast cells (vector vs. eIF4E). Error bars represent SD.     57   EI  F4E RNA REGULON PROMOTES A  KT   SIGNALING   •   CULJKOVIC ET AL.
given that eIF4E has additional activities. For instance, eIF4E 
also up-regulates the expression of many downstream effectors 
of Akt1 (see the last Results section). Finally, NBS1 does not 
rescue Akt1 
   /     cells relative to vector controls, which is consis-
tent with NBS1 acting, at least in part, through Akt1. Thus, con-
sistent with our previous fi  ndings that eIF4E requires Akt1 for 
its survival functions, NBS1 partially rescues Akt wild-type 
cells but not Akt1 
   /     cells. 
 We extended our studies to determine the effects of knocking 
down Akt1 expression on the ability of NBS1 to rescue serum-
deprived NIH3T3 cells. NIH3T3 cells overexpressing NBS1 
or vector controls were serum deprived, and viability was as-
sessed using fl  ow cytometry. The effi  ciency of Akt1 knockdown 
and of NBS1 overexpression was assessed by Western blotting 
(Fig. S4 C). NBS1-overexpressing cells treated with scrambled 
controls versus siRNA to Akt1 had increased viability by about 
twofold (    40 vs.     20%; Fig. S4 D). This indicates that NBS1 
requires Akt1 for its ability to rescue serum-starved NIH3T3 cells, 
which is consistent with our model. 
  PML is a negative regulator of 
eIF4E-mediated apoptotic rescue 
  Clearly, the cell has developed mechanisms to control the pro-
liferative and survival functions of eIF4E. Our previous studies 
indicated that the PML is a potent inhibitor of eIF4E-dependent 
mRNA export (  Cohen et al., 2001  ;   Kentsis et al., 2001  ;   Topisirovic 
et al., 2003a; Culjkovic et al., 2005, 2006  ). The RING domain 
of PML directly interacts with the dorsal surface of eIF4E 
(including W73) and, thereby, reduces the affi  nity of eIF4E for 
the m 
7  G cap by over 100-fold (  Kentsis et al., 2001  ). Previous 
studies indicated that mutations of PML in the RING domain 
or of the dorsal surface of eIF4E (W73A) impaired the PML  –
  eIF4E interaction and thereby relieved the PML-mediated in-
hibition of eIF4E-dependent mRNA export (for review see 
  Culjkovic et al., 2007  ). Thus, we examined the possibility that 
the PML protein impairs the export of NBS1 mRNA and, thereby, 
impairs the eIF4E-dependent activation of Akt. Mutants were 
used to determine whether these effects were dependent on the 
PML – eIF4E  interaction. 
  PML overexpression suppressed mRNA export of NBS1 
and cyclin D1 (by acting on endogenous eIF4E) relative to vec-
tor controls or eIF4E-overexpressing cells (  Fig. 5  ). In cells ex-
pressing both PML and eIF4E, PML reduces the export of both 
NBS1 and cyclin D1 mRNAs relative to cells overexpressing 
eIF4E alone. Consistently, PML overexpression leads to a reduc-
tion in NBS1 and cyclin D1 protein levels relative to cells over-
expressing eIF4E alone (  Fig. 5 A  ). Next, we examined whether 
PML reduces eIF4E-dependent Akt activation. Coexpression of 
PML and eIF4E led to a reduction in the phosphorylation of Akt 
at both T308 and S473 relative to cells overexpressing eIF4E 
alone (  Fig. 5 A  ). Consistently, PML overexpression leads to the 
reduced phosphorylation of S6 as well as 4E-BP1 relative to vec-
tor or eIF4E-overexpressing cells. Thus, PML impairs eIF4E-
dependent Akt activation and the downstream events examined. 
  To demonstrate that these effects of PML are dependent on 
its interactions with eIF4E, we monitored the effects of the PML 
mutant defi  cient in eIF4E binding (RING) and an eIF4E mutant 
eIF4E-overexpressing cells treated with siRNA for NBS1 (siNBS1) 
or scrambled controls (scram). Our results demonstrate that ex-
port of cyclin D1 mRNA is not reduced by silencing NBS1 ex-
pression (Figs. S2 B and S3 D) and that cyclin D1 protein levels 
are up-regulated in eIF4E-overexpressing cells relative to con-
trols regardless of siRNA treatments (  Fig. 4 A  ). Thus, silencing 
of NBS1 expression does not impair eIF4E-dependent mRNA 
export of the transcripts examined. Together with the previously 
reported data on the effects of NBS1 on PI3K activation (  Chen 
et al., 2005, 2008  ;   Sagan et al., 2007  ) and the ability of the PI3K 
inhibitor LY294002 to inhibit this eIF4E activity (  Fig. 1 B  ), it ap-
pears that the requirement for NBS1 in eIF4E-mediated activa-
tion of Akt is linked to the ability of NBS1 to impact the upstream 
  activation of Akt, possibly at the level of PI3K. 
  eIF4E requires NBS1 for apoptotic rescue 
of serum-deprived ﬁ  broblasts 
  We extended our studies to examine whether the ability of 
eIF4E to up-regulate NBS1 was required, at least in part, for 
its apoptotic rescue function. NIH3T3 cells were treated with 
siRNA for NBS1 (siNBS1) or scrambled controls (scram) and 
were serum deprived and monitored for apoptosis as a function 
of eIF4E overexpression (  Figs. 4 B   and S3 B). Transfection of 
NIH3T3 cells overexpressing eIF4E with scrambled siRNA 
slightly reduced the viability of cells relative to untreated con-
trols (  Fig. 4 B  ;     80% relative to     90% in   Fig. 2  ). Knockdown 
of NBS1 led to a further reduction in the viability of cells that 
were serum deprived as well as not serum deprived. This is con-
sistent with a previous study indicating that NBS1 is required 
for viability in mouse models (  Zhu et al., 2001  ). 
  Strikingly, knockdown of NBS1 severely impaired the 
survival activity of eIF4E (  Fig. 4 B  ). Specifi  cally, eIF4E-
overexpressing NIH3T3 cells treated with scrambled controls dis-
played     70% viability relative to vector-transfected cells, which 
showed     45% viability. This is comparable with the rescue ob-
served in   Fig. 2 A  . However, when the eIF4E-over  expressing 
cells were treated with siRNA for NBS1, only     20% of cells 
were viable, threefold less than the scrambled siRNA-treated 
eIF4E-overexpressing cells, which were   70% viable. Together 
with the observations that eIF4E requires Akt for its rescue 
function and requires NBS1 to activate Akt, our data strongly 
suggest that the survival function of eIF4E requires its ability to 
activate Akt through NBS1. The same trends were observed in 
Akt wild-type MEFs (Fig. S3 B). 
  Next, we examined the effects of the ectopic expression of 
NBS1 on the ability to rescue Akt wild-type and Akt1 
   /     cells 
(Fig. S4, A and B; available at http://www.jcb.org/cgi/content/
full/jcb.200707018/DC1). Western blot analysis confi  rmed NBS1 
overexpression and the fact that NBS1 overexpression led to the 
increased activation of Akt in Akt wild-type cells but not in the 
Akt1 
   /     cells. NBS1-mediated Akt activation is consistent with 
previous studies (  Chen et al., 2005, 2008  ;   Yang et al., 2006; Lee 
et al., 2007  ). NBS1 partially rescues the Akt wild-type cells. 
This is consistent with eIF4E acting through NBS1. It is not 
surprising that NBS1 overexpression could not completely re-
capitulate the extent of rescue seen during eIF4E overexpres-
sion (    60% in NBS1 vs.     80% in eIF4E-overexpressing cells) JCB • VOLUME 181 • NUMBER 1 • 2008  58 
eIF4E-overexpressing cells (    40 vs.     80%). As with the afore-
mentioned results, experiments with PML RING and W73A 
eIF4E mutants indicated that PML must directly bind eIF4E to 
inhibit eIF4E  ’  s survival function (  Fig. 6 A  ). TUNEL assays 
yielded consistent results (  Fig. 6 B  ). Thus, PML impairs eIF4E-
mediated apoptotic rescue under serum deprivation conditions. 
  Finally, we examined the possibility that differences in 
PML status could account for the different effects of eIF4E on 
Akt1 
   /     versus Akt wild-type cells. Our studies demonstrate 
that there are no signifi  cant differences in PML levels or local-
ization between these cell lines (Fig. S1, C and D). 
  eIF4E is positioned to have a two-tier 
effect on Akt expression 
  Given that eIF4E modulates gene expression combinatorially 
(  Culjkovic et al., 2006  ), we investigated whether other known 
targets of eIF4E-dependent mRNA export and/or eIF4E-sensi-
tive translation also acted in Akt signaling. Inspection of previ-
ously reported eIF4E mRNA export targets (  Culjkovic et al., 
2006  ) demonstrated that this is indeed the case (i.e., eIF4E co-
ordinately up-regulated effectors of the Akt pathway, including 
cyclins A2 [  Heron-Milhavet et al., 2006  ], B1 [  Lee et al., 2005  ], 
and E [  Hlobilkova et al., 2006  ], c-Myc [  Ahmed et al., 1997  ], 
Mdm2 [  Gottlieb et al., 2002  ], cyclin D1 [  Muise-Helmericks et al., 
1998  ], and NBS1 [  Fig. 5  ;   Culjkovic et al., 2006]  ). This list is 
not inclusive, and as more eIF4E mRNA targets are identifi  ed, 
defi  cient in binding PML (W73A). Coexpression of PML RING + 
eIF4E or PML + W73A eIF4E did not impair eIF4E-dependent 
Akt activation as observed by Western blotting for both T308 and 
S473 Akt sites relative to cells expressing eIF4E alone (  Fig. 5 A  ). 
As expected, the PML RING mutant did not inhibit eIF4E-
dependent mRNA export of either NBS1 or cyclin D1 mRNA 
(PML RING + eIF4E vs. PML + eIF4E;   Fig. 5 B  ). Reciprocally, 
wild-type PML did not impair W73A eIF4E-dependent mRNA 
export of NBS1 or cyclin D1 (  Fig. 5 A  ). As expected, export for 
the negative control for mRNA export, VEGF, was unchanged 
by either eIF4E or PML overexpression. Thus, PML must directly 
bind to eIF4E to impair eIF4E-dependent NBS1 mRNA export to 
thereby reduce NBS1 protein levels and activate Akt. Importantly, 
the expression of PML or PML RING did not alter the expression 
of eIF4E or Akt (  Fig. 5 A  ), nor did the expression of eIF4E or 
W73A eIF4E modulate PML levels. 
  We hypothesized that PML should impair eIF4E-depen-
dent rescue of serum-deprived fi  broblasts from apoptosis. Before 
serum starvation, PML and eIF4E overexpression do not appear 
to impact viability (  Fig. 6  ). However, in serum-deprived cells, 
PML overexpression results in reduced viability relative to vec-
tor controls (  Fig. 6 A  ), which is consistent with a previous study 
(  Borden et al., 1997  ). eIF4E-overexpressing cells result in 
enhanced viability versus vector controls (twofold) and PML 
(threefold)-expressing cells. In contrast, in cells coexpressing 
PML and eIF4E, viability was substantially reduced relative to 
  Figure 5.       The eIF4E inhibitor PML abrogates the eIF4E  –  Akt1 pathway, whereas the PML RING mutant does not.   (A) Western blot analysis of whole cell 
extracts from stably transfected NIH3T3 cells overexpressing constructs as indicated. Note that the antibody used for PML only detects exogenous PML. 
    -Actin is shown as a loading control. (B) Parallel qPCR experiments showing relative fold increase of the cytoplasmic/nuclear (C/N) ratio of eIF4E target 
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fi  ndings are consistent with previous reports that eIF4E overexpres-
sion substantially reduces cellular susceptibility to apoptotic stimuli 
(  Polunovsky et al., 1996, 2000  ;   Tan et al., 2000; Li et al., 2003, 
2004  ). Our experiments also suggest that these two biological 
  effects of eIF4E overexpression, proliferation and apoptotic rescue, 
are intrinsically linked through modulation of this RNA regulon. 
 In this model, eIF4E coordinately exports mRNAs of down-
stream effectors of the Akt signaling pathway, allowing their 
enhanced production (  Fig. 7  ). Coordinated mRNA export is 
achieved by a common element in the 3     UTR of these mRNAs, 
the 4E-SE (  Culjkovic et al., 2006  ). Our fi  ndings indicate that 
eIF4E impacts the Akt pathway at least at two levels. First, eIF4E 
acts at the level of Akt phosphorylation via enhancing produc-
tion of the NBS1 protein. Several studies indicate that NBS1 is an 
upstream activator of PI3K (  Chen et al., 2005  ;   Yang et al., 2006; 
Lee et al., 2007  ;   Sagan et al., 2007  ), and, recently, NBS1 was 
it is likely that many of these will also be downstream effectors 
of the Akt signaling pathway. Thus, eIF4E is positioned to affect 
the Akt pathway at two levels: Akt activation and up-regulation 
of the downstream effectors of Akt. 
  Discussion 
 We provide evidence that via the RNA regulon model, eIF4E modu-
lates the PI3K  –  Akt signaling axis and coordinates its regulation 
(  Fig. 7  ). This is consistent with previous studies, which indicated 
that eIF4E is a node in a regulon that governs cell cycle progression 
via coordinately modulating the expression of genes involved in this 
process (  Culjkovic et al., 2006;   for review see   Culjkovic et al., 
2007 ). The studies reported here indicate that eIF4E, using the same 
strategies, enhances survival signaling, enabling eIF4E to drive pro-
liferation while inhibiting apoptosis in immortalized cell lines. Our 
  Figure 6.       The eIF4E inhibitor PML impedes eIF4E-dependent apoptotic rescue through the RING domain of PML.   (A) Bar graphs represent quantitative mea-
surements of apoptosis using annexin V and PI staining of the indicated NIH3T3-derived cells. Bar color is as follows: annexin V 
     /PI 
     , blue; annexin V 
+  /PI 
     , 
yellow; annexin V 
+  /PI 
+  , red; annexin V 
     /PI 
+  , black. Errors were within 10% (Table S2, available at http://www.jcb.org/cgi/content/full/jcb.200707018/DC1). 
NC, normal condition; SS, serum starvation. (B) Conﬁ  rmation of apoptosis from TUNEL experiments (blue, DAPI; red, apoptotic). Bars, 50   μ  m.     JCB • VOLUME 181 • NUMBER 1 • 2008  60 
  The effects of eIF4E overexpression on 4E-BP1 phosphory-
lation are interesting and suggest that eIF4E could be involved 
in a positive feedback loop in which it activates its translational 
activity by indirectly using its mRNA export activity to increase 
levels of hyperphosphorylated 4E-BP1 without changing levels 
of total 4E-BP1 protein. However, translation of eIF4E-sensitive 
mRNAs (e.g., ODC) is not signifi  cantly elevated in 4E-BP1 
   /   , 
4E-BP2 
   /    , or 4E-BP1 
   /   /4E-BP2 
   /     cells (  Blackshear et al., 
1997  ;   Tsukiyama-Kohara et al., 2001; Banko et al., 2006  ; 
  Le Bacquer et al., 2007  ). Enhancement of the formation of trans-
lationally active eIF4E complexes is estimated to be within the 
SD of the measurements (    1.5-fold;   Banko et al., 2006  ), and 
enhanced polysomal loading of eIF4E-sensitive mRNAs was not 
reported in these studies. These animals are normal in terms of 
their size, with 4E-BP1 
   /     and  4E-BP1 
   /   /4E-BP2 
   /     having 
only signifi  cant defects in adipogenesis and the insulin response 
(  Tsukiyama-Kohara et al., 2001; Le Bacquer et al., 2007  ). Inter-
estingly, 4E-BP1 
   /    cells respond to rapamycin (in terms of growth 
arrest) to the same extent as wild-type controls (  Blackshear 
et al., 1997  ). The phenotype of these mice was predicted to be 
much more marked, as it was assumed that these mice would be 
subject to a wide range of cancers. This is not the case. It is pos-
sible that 4E-BP3 can substitute for the other binding proteins. 
These experiments suggest that there is signifi  cant redundancy 
in the factors that regulate eIF4E. Thus, although 4E-BP1 phos-
phorylation is a marker of Akt activation, it is not clear the ex-
tent to which 4E-BP1 phosphorylation alone is predictive of the 
translational activity of eIF4E. In the case of our experiments, 
although eIF4E does stimulate 4E-BP1 phosphorylation through 
Akt activation, the signifi  cance of this effect alone on eIF4E ac-
tivity will require further study. 
  The cell has clearly developed master control switches to 
control the RNA regulon, in this case in the form of PML, to at-
tenuate the effects of eIF4E (  Culjkovic et al., 2006;   for review 
see   Culjkovic et al., 2007  ). Thus, the cell can use PML to shut 
down this complicated survival network by directly targeting 
shown to directly interact through a novel, highly conserved 
C-terminal motif with p110    , a catalytic subunit of PI3K, enabling 
stimulation of PI3K activity (  Chen et al., 2008  ). Consistent 
with previous studies, we show that eIF4E-NBS1 activation of 
Akt is PI3K dependent because LY294002 impairs this activa-
tion (  Chen et al., 2005, 2008  ;   Sagan et al., 2007  ). Interest-
ingly, eIF4E enhances the production of ornithine decarboxylase 
(ODC) at both the mRNA export and translation levels ( Rousseau 
et al., 1996  ). ODC overexpression can lead to Akt activation 
independently of PI3K (  Hayes et al., 2006  ), indicating that in 
some contexts, eIF4E may activate Akt independently of the 
NBS1-PI3K-Akt axis. Thus, it is possible that the eIF4E  –  Akt 
pathway is parallel to the PI3K  –  Akt pathway. Second, eIF4E 
overexpression leads to increased protein levels for several 
downstream effectors of Akt (  Fig. 7  ;   Culjkovic et al., 2006  ). In 
summary, eIF4E is positioned to amplify the Akt survival sig-
naling pathway. 
  Previous studies have suggested that eIF4E overexpression 
did not lead to the activation of Akt1 or of p70S6K and 4E-BP1 
(  Khaleghpour et al., 1999  ). For Akt activation analysis, these ex-
periments were performed using a tetracycline-inducible system. 
However, tetracycline alone in parental cell lines quite markedly 
enhanced Akt phosphorylation (  Khaleghpour et al., 1999  ). Simi-
larly, tetracycline alone markedly affects the phosphorylation 
and total levels of 4E-BP1 and p70S6K (  Khaleghpour et al., 
1999  ). Additionally, in some cases, phosphorylation and total 
levels of these proteins were different between the three eIF4E-
overexpressing clones before induction. The one experiment 
conducted in the absence of the tetracycline-inducible system 
showed that eIF4E overexpression led to increased levels of 
     phosphorylation of BP1 (consistent with our fi  ndings), with a 
slight reduction in      phosphorylation (  Khaleghpour et al., 1999  ). 
Thus, many of the effects in this study seem to be related to ob-
serving the effects of eIF4E in the background of tetracycline 
treatment. This is the key difference between our study and the 
previous one (  Khaleghpour et al., 1999  ). 
  Figure 7.       Comparison models summarizing how eIF4E is not only downstream of the PI3K  –  AKT pathway (left) but can modulate this PI3K  –  Akt axis through 
NBS1 (right).   Furthermore, several downstream effectors of Akt (e.g., cyclin A2, B1, D1, and E, Mdm2, and c-Myc) are also targets for eIF4E regulation at 
the mRNA export level, giving rise to a putative feedback loop. For simplicity, arrows indicate downstream effects (such as phosphorylation), but arrows do 
not necessarily indicate a single-step process. In yellow are some of the known subsets of mRNAs sensitive to eIF4E export activity that are also downstream 
effectors of Akt. PML  ’  s role as an inhibitor of eIF4E is also shown.     61   EI  F4E RNA REGULON PROMOTES A  KT   SIGNALING   •   CULJKOVIC ET AL.
GFP proﬁ  les of murine stem cell virus (MSCV) stably transfected Akt wild-type 
and Akt1 
    /      cells are shown in Fig. S1 A. The PML RING mutant (double 
point mutation of the ﬁ  rst two cysteines to alanines in the RING domain of 
PML; required for PML function) was previously described (  Borden et al., 
1995  ). The MSCV-pgk-YFP-Akt1 expression construct was made by blunt end 
ligation using an XhoI site. 
  Cell culture and treatments 
  Akt1 and Akt1 
    /      cells were used to determine the importance of Akt1 to 
eIF4E-mediated apoptotic rescue. However, these cells were much less 
transfectable than NIH3T3 cells, which were used in other experiments, 
especially where multiple transfections were necessary. Indeed, Akt1 and 
Akt1 
    /      cells had to be retrovirally transduced. Note that Akt MEFs were 
immortalized by passaging multiple times (  Cho et al., 2001  ). The cells 
used were maintained in DME with 100 U/ml penicillin G sodium and 
100   μ  g/ml streptomycin sulfate (all were obtained from Invitrogen), with 
the addition of 10% newborn calf serum for MEF Akt1 wild type  –   and 
Akt1 
    /     -derived cells, 10% FCS for Bosc-23 cells, and 10% calf serum 
with 1 mg/ml G418 (Invitrogen) and 1   μ  g/ml puromycin (Sigma-Aldrich) 
for NIH3T3-derived cells. eIF4E wild-type and mutant retroviral vectors 
were transiently transfected into the Bosc-23 Eco packaging line (a gift 
from G. Sauvageau, Institute for Research in Immunology and Cancer, 
University of Montreal, Quebec, Canada), and retroviral supernatants 
were used to infect MEF Akt1 wild-type and Akt1 
    /      cells (a gift from 
M. Birnbaum, Howard Hughes Medical Institute, University of Pennsylva-
nia School of Medicine, Philadelphia, PA). GFP 
+   cells were isolated using a 
cell sorter (FACSAria; BD Biosciences). eIF4E and PML stably transfected 
NIH3T3 cells were generated as described previously (  Cohen et al., 
2001  ;   Topisirovic et al., 2003a; Kentsis et al., 2004  ). For siRNA experi-
ments, indicated cells were transfected with Lipofectamine 2000 (Invitro-
gen) and 20 nM siRNA duplex (si_NBS1, MMS.RNAI.NO13752.2.2; 
si_eIF4E, MMU.RNAI.N007917.1.1 and MMU.RNAI.N007917.1.2 
[all were obtained from Integrated DNA Technologies]) according to the 
manufacturer  ’  s instructions. Cells were analyzed 72 h after transfection. 
LY294002 used in treatment experiments was cell culture grade (Sigma-
Aldrich) and was used at 50   μ  M for 1 h. 
  Western blot analysis and antibodies 
  Western analysis was performed as described previously (  Topisirovic et al., 
2003a; Kentsis et al., 2004  ), with a modiﬁ  ed lysis buffer (40 mM Hepes, 
pH 7.5, 120 mM NaCl, 1 mM EDTA, 10 mM     -glycerophosphate, 50 mM 
NaF, 0.5   μ  M NaVO  3  , and 1% [vol/vol] Triton X-100 supplemented with 
complete protease inhibitors [all were purchased from Sigma-Aldrich]). In 
addition, blots for immunophosphoprotein detection were blocked in BSA 
blocking solution (2% [wt/vol] BSA [Sigma-Aldrich] in TBS  –  Tween 20), and 
primary antibodies were diluted in BSA blocking solution. Antibodies used 
for immunoblotting were obtained from Cell Signaling Technology unless 
otherwise mentioned: mAb anti-eIF4E (BD Biosciences); mAb anti-PML (Mil-
lipore); pAb anti-NBS1; mAb anti  –  cyclin D1 (BD Biosciences); pAb anti-
VEGF (Santa Cruz Biotechnology, Inc.); pAbs anti-Akt, antiphospho-Thr308 
Akt, and mAb antiphospho-Ser473 Akt; pAbs anti-S6 and antiphospho-S6 
ribosomal protein; pAbs anti  –  4E-BP1 and antiphospho-Thr37/46 4E-BP1; 
mAb anti-GAPDH (MAB374; Chemicon); mAb anti  –      -actin (AC-15; Sigma-
Aldrich); and mAb anti  –      -tubulin (Sigma-Aldrich). 
  Apoptosis assays 
  Exponentially growing cell cultures derived from MEF Akt1 wild-type, 
Akt1 
    /     , and NIH3T3 cells were shifted to 0.1% serum conditions for 18 h. 
For annexin V  –  allophycocyanin (BD Biosciences) and PI (Sigma-Aldrich) 
staining, cells and initial PBS washes were collected and treated according 
to the manufacturer  ’  s instructions (BD Biosciences). Stained cells were ana-
lyzed on a ﬂ  ow cytometer (LSRII; BD Biosciences), with early apoptotic cells 
scored as annexin V positive and PI negative to exclude necrotic cells. 
  Assays were performed in triplicate. 
  TUNEL, immunoﬂ  uorescence, and laser-scanning confocal microscopy 
  For TUNEL staining, preseeded cells on coverslips were serum withdrawn, 
ﬁ  xed, and stained with the In Situ Cell Death Detection kit (TMR red; Roche) 
according to the manufacturer  ’  s instructions and were then mounted in 
Vectashield with DAPI (Vector Laboratories). Fluorescence from several 
ﬁ   elds was observed using a 20  ×   optical magniﬁ   cation and 1  ×   digital 
zoom on a laser-scanning confocal microscope (LSM510; Carl Zeiss, Inc.), 
exciting at 405 and 543 nm at RT. All channels were detected separately, 
and no cross talk between the channels was observed. The confocal micro-
graphs represent a single optical section through the plane of the cell. 
just one node of the network, eIF4E. PML is a potent inhibitor 
of eIF4E, where it not only inhibits eIF4E-dependent mRNA 
export but, when in the cytoplasm, can inhibit cap-dependent 
translation as well (  Kentsis et al., 2001  ). Furthermore, the abil-
ity of PML to promote apoptosis via inhibiting eIF4E-dependent 
rescue (  Fig. 6  ) provides the first molecular explanation for 
previous observations that the proapoptotic activity of PML is 
independent of on-going transcription (  Quignon et al., 1998  ) 
because, at the time of this previous study, the link between 
PML and eIF4E was not known. Thus, our results suggest a 
model for how PML stimulates apoptosis in a transcriptionally 
independent manner. Finally, our results are consistent with re-
cent observations that Akt is more active in PML 
   /     cells  than 
in littermate controls (  Trotman et al., 2006  ). Although another 
mechanism for PML inactivation of Akt was proposed there, 
our results do not exclude the possibility that PML acts as a 
negative regulator of Akt directly in addition to its effects on the 
eIF4E regulon described here. Also, overexpression of the pro-
line-rich homeodomain protein, another negative regulator of 
eIF4E-dependent mRNA export (  Topisirovic et al., 2003a  ), also 
decreases the phosphorylation of Akt (unpublished data). 
  Clearly, other cellular modulators of eIF4E function, such 
as En2, HoxA9, and 4E-BPs, are positioned to potently modu-
late this regulon (  Sonenberg and Gingras, 1998  ;   Topisirovic 
et al., 2003a, 2005; Brunet et al., 2005  ;   Topisirovic and Borden, 
2005  ). Regulators such as HoxA9 are particularly potent, as 
HoxA9 stimulates both eIF4E-dependent mRNA export and 
eIF4E-dependent translation (  Topisirovic et al., 2005  ). Further-
more, there are likely feedback loops on this regulon. For instance, 
c-Myc is an mRNA export and translational target of eIF4E 
(  Clemens and Bommer, 1999  ;   Culjkovic et al., 2006  ). Interest-
ingly, both eIF4E and NBS1 are direct transcriptional targets of 
c-Myc (  Chiang et al., 2003  ;   Schmidt, 2004  ). This provides a 
putative positive feedback loop between these proteins and Akt 
activation. Other control loops likely exist in this regulon. For 
instance, PML and NBS1 proteins interact at PML bodies ( Naka 
et al., 2002  ), suggesting that they could impact the function of 
each other, thereby affecting the eIF4E RNA regulon at yet 
 another  level. 
  Collectively, our fi  ndings suggest that eIF4E coordinately 
modulates proliferation and survival signaling gene expression 
networks. The RNA regulon model provides a theoretical con-
text to understand eIF4E  ’  s combinatorial effects on gene expres-
sion and its wide-ranging biological activities. As such, eIF4E 
presents a potent therapeutic target. The fi  rst therapeutic strategy 
developed to target eIF4E involved use of a physical mimic of 
the m 
7  G cap, ribavirin (  Kentsis et al., 2004, 2005  ). Ribavirin is 
now being tested in a clinical trial in leukemias characterized by 
dysregulated eIF4E activity (www.ribatrial.com). These studies 
will yield the fi  rst clinical insights into the therapeutic effi  cacy 
of targeting an RNA regulon and of targeting eIF4E. 
  Materials and methods 
  Constructs 
  pLINKSV40-PML, pcDNA eIF4E, MSCV-pgk-GFP-eIF4E wild type, and mutant 
expression constructs were previously described (  Cohen et al., 2001  ;   Topisirovic 
et al., 2003b; Culjkovic et al., 2005  ;   Topisirovic and Borden, 2005  ). JCB • VOLUME 181 • NUMBER 1 • 2008  62 
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